| Evaluation of formulation parameters on permeation of ibuprofen from topical formulations using Strat-M® membrane PK Bolla, BA Clark, A Juluri, HS Cheruvu, J Renukuntla Pharmaceutics 12 (2), 151, 2020 | 112 | 2020 |
| Intraoperative serum and tissue activity of cefazolin and cefoxitin JT DiPiro, JJ Vallner, TA Bowden, BA Clark, JF Sisley Archives of Surgery 120 (7), 829-832, 1985 | 107 | 1985 |
| Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. JT DiPiro, KA Michael, BA Clark, P Dickson, JJ Vallner, TA Bowden Jr, ... Clinical Pharmacy 5 (2), 153-155, 1986 | 66 | 1986 |
| Selection of cryoprotectant in lyophilization of progesterone-loaded stearic acid solid lipid nanoparticles TM Amis, J Renukuntla, PK Bolla, BA Clark Pharmaceutics 12 (9), 892, 2020 | 52 | 2020 |
| Lutein-loaded, biotin-decorated polymeric nanoparticles enhance lutein uptake in retinal cells PK Bolla, V Gote, M Singh, M Patel, BA Clark, J Renukuntla Pharmaceutics 12 (9), 798, 2020 | 35 | 2020 |
| Intraoperative serum concentrations of cefazolin and cefoxitin administered preoperatively at different times. JT DiPiro, JJ Vallner, TA Bowden Jr, B Clark, JF Sisley Clinical Pharmacy 3 (1), 64-67, 1984 | 17 | 1984 |
| In Vitro/in Vivo Evaluation Of A Liquid Sustained Release Dosage Form Of Chlorpheniramine OL Sprockel, JC Price, R Jennings, RL Tackett, S Hemingway, B Clark, ... Drug Development and Industrial Pharmacy 15 (9), 1393-1404, 1989 | 8 | 1989 |
| Advances in in-vitro bioequivalence testing methods for complex ophthalmic generic products J Renukuntla, SS Palakurthi, PK Bolla, BA Clark, SHS Boddu, P Manda, ... International Journal of Pharmaceutics 627, 122209, 2022 | 5 | 2022 |
| Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders AMM Mjalli, BA Clark, DR Polisetti, JC Quada Jr, MCV Lopez, ... US Patent App. 14/799,222, 2015 | 5 | 2015 |
| Drying and dryers AJ Hlinak, BA Clark Encyclopedia of pharmaceutical technology 1, 1030-1031, 2002 | 5 | 2002 |
| Sealing arrangement for syringe MJ Gibler, MA Bennett, KR Waeber, KE Hogue, CL Gillum, PA Harrell, ... US Patent 10,195,350, 2019 | 4 | 2019 |
| Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using same BA Clark, U Shah, DD Dubash, PD Curry, M Scoggins US Patent App. 12/245,399, 2009 | 3 | 2009 |
| Size exclusion chromatographic determination of PEG 3350 in human plasma and urine BA Clark, JT DiPiro, DE Cadwallader Analytical letters 20 (2), 293-301, 1987 | 3 | 1987 |
| Design and preclinical evaluation of nicotine–stearic acid conjugate-loaded solid lipid nanoparticles for transdermal delivery: a technical note J Renukuntla, S Peterson-Sockwell, BA Clark, NH Godage, E Gionfriddo, ... Pharmaceutics 15 (4), 1043, 2023 | 2 | 2023 |
| Stability indicating HPLC analysis of dibromodulcitol in aqueous solutions BA Clark, DE Cadwallader, MJ Salamone Analytical letters 21 (3), 411-422, 1988 | 2 | 1988 |
| Sealing arrangement for syringe MJ Gibler, MA Bennett, KR Waeber, KE Hogue, CL Gillum, PA Harrell, ... US Patent App. 16/267,318, 2019 | | 2019 |
| Combinaciones de un agonista del GLPR1 y metformina y el uso de estos para el tratamiento de la diabetes tipo 2 y otros trastornos AMM Mjalli, BA CLARK, DR Polisetti, JJC Quada, MCV Lopez, ... | | 2018 |
| and Dryers ADDEJ Hlinak, BA Clark Encyclopedia of Pharmaceutical Technology 3, 1435, 2007 | | 2007 |
| Omar L. Sprockelk, James C. Price**, Robert Jennings RL Tackett, S Hemingway, B Clark, RE Laskey | | 1989 |
| PART I. ANALYSIS OF PEG 3350 IN PLASMA AND URINE WITH ELIMINATION ESTIMATES. PART II. BASE-CATALYZED DEGRADATION OF DIBROMODULCITOL IN AQUEOUS SOLUTIONS BA Clark University of Georgia, 1987 | | 1987 |
